Work

Figure S1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

Year: 2023
Type: other
Abstract: Figure S1. Survival Characteristics by Response
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4384818497
Cites:
Cited by:
Related to: 10